Warner Bros. Discovery, Inc.
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

Last updated:

Abstract:

The present invention relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with HDAC6, having a Formulae I or Formula II: ##STR00001## where R, L, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, Y.sup.1, Y.sup.2, Y.sup.3, and Y.sup.4 are described herein.

Status:
Application
Type:

Utility

Filling date:

17 Dec 2020

Issue date:

8 Jul 2021